Luminta, Ira Mae B.

HRN: 28-71-26  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
CEFTRIAXONE 1G (VIAL)
03/19/2026
03/26/2026
IV
1.5 GMS
BID
Pneumonia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: